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Abstract
Background: Optimally, expanded HIV testing programs should reduce barriers to testing while attracting new and high-
risk testers. We assessed barriers to testing and HIV risk among clients participating in mobile voluntary counseling and
testing (MVCT) campaigns in four rural villages in the Kilimanjaro Region of Tanzania.
Methods: Between December 2007 and April 2008, 878 MVCT participants and 506 randomly selected community residents
who did not access MVCT were surveyed. Gender-specific logistic regression models were used to describe differences in
socioeconomic characteristics, HIV exposure risk, testing histories, HIV related stigma, and attitudes toward testing between
MVCT participants and community residents who did not access MVCT. Gender-specific logistic regression models were
used to describe differences in socioeconomic characteristics, HIV exposure risk, testing histories, HIV related stigma, and
attitudes toward testing, between the two groups.
Results: MVCT clients reported greater HIV exposure risk (OR 1.20 [1.04 to 1.38] for males; OR 1.11 [1.03 to 1.19] for females).
Female MVCT clients were more likely to report low household expenditures (OR 1.47 [1.04 to 2.05]), male clients reported
higher rates of unstable income sources (OR 1.99 [1.22 to 3.24]). First-time testers were more likely than non-testers to cite
distance to testing sites as a reason for not having previously tested (OR 2.17 [1.05 to 4.48] for males; OR 5.95 [2.85 to 12.45]
for females). HIV-related stigma, fears of testing or test disclosure, and not being able to leave work were strongly
associated with non-participation in MVCT (ORs from 0.11 to 0.84).
Conclusions: MVCT attracted clients with increased exposure risk and fewer economic resources; HIV related stigma and
testing-related fears remained barriers to testing. MVCT did not disproportionately attract either first-time or frequent
repeat testers. Educational campaigns to reduce stigma and fears of testing could improve the effectiveness of MVCT in
attracting new and high-risk populations.
Citation: Ostermann J, Reddy EA, Shorter MM, Muiruri C, Mtalo A, et al. (2011) Who Tests, Who Doesn’t, and Why? Uptake of Mobile HIV Counseling and Testing
in the Kilimanjaro Region of Tanzania. PLoS ONE 6(1): e16488. doi:10.1371/journal.pone.0016488
Editor: Landon Myer, University of Cape Town, South Africa
Received October 18, 2010; Accepted December 29, 2010; Published January 31, 2011
Copyright:  2011 Ostermann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The primary source of funding for this study was the Duke University Center for AIDS Research (CFAR), supported by the National Institutes of Health
(NIH; www.nih.gov) (P30 AI 64518). Various investigators were also supported by the following: Fogarty International Center AIDS International Training and
Research Program (NIH D43 TW006732; Dr. Njau), Duke Clinical Trials Unit and Clinical Research Sites (NIH U01 AI06984: Drs. Bartlett, Crump, and Thielman),
International Studies on AIDS Associated Coinfections (ISAAC) award (NIH U01 AI-03-036; Dr. Bartlett, Dr. Crump, Mrs. Itemba, Mr. Mtalo, Mr. Muiruri, and Dr.
Thielman), AIDS Research and Training Grant (NIH T32 AI007392-18; Dr. Reddy), Hubert-Yeargan Center for Global Health, Duke University Medical Center (http://
www.dukeglobalhealth.org) (Dr. Shorter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: n.thielman@duke.edu
Introduction
Universal testing and immediate treatment of HIV-infected
individuals could dramatically reduce or even eliminate HIV
transmission [1,2]. Yet, despite global expansion of HIV
counseling and testing options [3], serostatus awareness is low
in heavily affected communities in sub-Saharan Africa [4,5],
and late presentation to care remains common [6]. There is a
pressing need to understand which HIV counseling and testing
strategies are most successful in recruiting new and high risk
testers in order to improve testing uptake and facilitate early
linkage to care.
Mobile HIV voluntary counseling and testing (MVCT) has been
promoted as a means of reaching populations with limited access
to HIV testing, and has been effective in attracting large numbers
of new testers in countries such as Tanzania, Zimbabwe and
Cameroon [7,8,9], but there are limited data describing the
characteristics of community members who do not access this
opportunity. While early data from a large randomized study
offering in-village mobile testing demonstrated 3–13 times greater
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voluntary counseling and testing (VCT) uptake in intervention
villages compared with control villages which had access only to
nearby facility-based VCT, only 30% of residents ages 18–32 had
accessed the intervention in the Tanzania sites after 24 months [4].
In 2007 and 2008, a national voluntary counseling and HIV
testing campaign in Tanzania, which included a substantial
MVCT component, attracted more than 4.8 million testers [9].
However, no information is available about the extent to which
new or high risk clients presented for testing, and it remains
unknown whether such campaigns, particularly in rural areas, can
overcome important non-economic barriers to HIV testing,
including HIV related stigma and fears of testing [10,11]. Whether
expanded HIV testing strategies reduce such barriers and
successfully attract new and high risk testers, or preferentially
attract lower risk repeat testers, has substantial implications for the
strategies’ cost effectiveness and for the possible success of
universal testing and treatment policies.
Comparing characteristics of MVCT participants and randomly
selected community residents who did not participate in MVCT,
we examined selection effects, which we defined as systematic
differences between MVCT participants and community residents
who did not undergo VCT, in MVCT campaigns across four rural
village clusters in the Kilimanjaro Region of Tanzania. We
evaluated differences in socioeconomic and HIV risk character-
istics, HIV testing histories, HIV related stigma, and attitudes
toward testing, to assess the extent to which MVCT campaigns
attracted new and high risk testers and reduced barriers to HIV
testing.
Methods
Ethics Statement
Written informed consent was obtained from all study
participants prior to enrollment. Ethical approval was obtained
from the Kilimanjaro Christian Medical College Research Ethics
Committee, a Duke University Health System Institutional
Review Board, and the Tanzanian National Institute of Medical
Research National Medical Research Coordinating Committee.
Study Design
The study was conducted between December 2007 and April
2008 in 4 rural village clusters in three districts of the Kilimanjaro
Region of Tanzania. In each village, randomly selected commu-
nity respondents aged 18 to 50 years were given HIV Awareness,
Attitudes, and Risk Surveys (HAARS). Subsequently, free MVCT
was offered, and HAARS were administered to eligible clients
during pretest counseling. HIV risk, testing history, socioeconomic
characteristics, and HIV-related stigma were compared between
MVCT participants and randomly selected community respon-
dents who did not access MVCT.
Village Selection. Villages were chosen on the advice of local
leaders, and priority was given to communities that did not have
in-village HIV testing services at the time of project planning.
Population sizes of the village clusters ranged from 2,600–4,500,
with a total population of 15,400, of whom 6,300 (41%) were
estimated to be between the ages of 18 to 50 years [12]. The
distance from villages to the nearest towns or urban centers was
approximately 10 to 15 kilometers.
Community Sample. Aerial photographs were used to
define the geographic sampling frame and to randomly select
150 index structures or buildings in each village cluster. In each
structure, one male and one female respondent were randomly
selected from all male and female residents aged 18–50.
Replacement structures were selected when no eligible
respondent resided in the structure or no eligible respondent was
enrolled after up to three contact attempts.
Mobile VCT program and clients
Following the HAARS assessments, free MVCT was offered for
2 to 3 weeks in up to 2 locations per village. Testing locations
typically included dispensaries, ward offices, and schools. MVCT
staff were employed by KIWAKKUKI, a women-led HIV/AIDS
service organization in nearby Moshi, Tanzania; none of the team
members were residents of any of the four study villages.
Campaigns were advertised at ward leaders’ offices, churches,
and other key places, as well as via bullhorn advertising on the 2
days preceding and the first day of testing at each location.
Consenting MVCT clients aged 18 to 50 years completed pretest
counseling and a HAARS assessment. Phlebotomy and rapid
HIV-testing were followed by post-test counseling, according to
Tanzanian Ministry of Health Guidelines [13]. Samples were
tested using Capillus (Trinity Biotech PLC, Bray, County
Wicklow, Ireland) and Determine (Abbott Laboratories, Abbott
Park, IL, U.S.A.) rapid HIV1/2 antibody tests [14]. Blood samples
with contradictory test results, and every 20th blood sample (for
quality assurance), were sent to the zonal referral hospital for
confirmatory testing via Vironostika HIV-1 microElisa assay
(Organon Teknika, Charlotte, N.C., U.S.A.).
HIV Awareness, Attitudes, and Risk Surveys (HAARS)
Trained surveyors and VCT counselors, respectively, adminis-
tered HAARS in respondents’ homes (community sample) and
during pre-test counseling at the MVCT sites (MVCT clients).
HAARS included demographic characteristics, sexual history and
current sexual practice, HIV testing history, HIV knowledge,
perceived HIV risk, and HIV-related fears and stigma.
Study Population
883 MVCT clients and 644 community respondents aged 18 to
50 years participated in HAARS. Nine community respondents
(1.4%) and 5 MVCT clients (0.6%) who reported that they had
previously tested positive for HIV were excluded from analyses. Of
the remaining 635 randomly selected community respondents, 129
(20.3%) subsequently participated in MVCT and were analyzed as
MVCT testers; 506 respondents who did not participate in
MVCT formed the comparison group.
Analysis Overview
Factors associated with MVCT participation, risk selection
among MVCT clients, and barriers to HIV testing, were evaluated
by comparing characteristics of clients presenting for HIV testing
and randomly selected community respondents who did not
present for testing. Gender-specific multivariable logistic regres-
sion models were used to identify correlates of MVCT
participation.
Measures
Socio-demographic characteristics. Socio-demographic
characteristics included respondent age (18–24; 25–29; 30–39; 40+
years), marital status (married; divorced; widowed; single), and
education (any secondary education vs. none), whether the
respondent had any children, weekly household expenditures above
or below 10,000 Tanzanian Shillings (TZS), and respondents’ main
source of income (‘‘farming’’; ‘‘other stable income source’’ which
included business, skilled workers, salaried workers, and students; and
‘‘unstable income source’’ including unskilled workers, the
unemployed, and respondents with other income sources).
Barriers to Mobile HIV Testing Uptake in Tanzania
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Risk of HIV seropositivity. Participants’ risk of HIV
seropositivity was described by variables in two domains. Socio-
demographic correlates of HIV infection included respondents’
age and marital status, unemployment, and whether the
respondent had any children. Exposure risk was described by
the number of lifetime sexual partners; multiple sexual partners in
the past 3 months; whether any partner had ever tested HIV
seropositive; whether the respondent suspected that any of their
partners had HIV; and whether any of the respondent’s sexual
partners had died. Risk variables were combined into indices
describing clients’ socio-demographic risk, exposure risk, and total
risk of HIV infection. Contributions of each risk factor to HIV
seropositivity were identified using data from a cohort of 5,628
clients presenting for HIV testing between 2005 and 2008 at a
freestanding VCT site in nearby Moshi, Tanzania
(KIWAKKUKI; see Table S1 for details). Data from this cohort
were previously used to assess correlates of HIV infection and
trends in rates of HIV seropositivity among VCT clients in the
Kilimanjaro Region of Tanzania [15,16]. Risk indices ranged
from 0 (low risk) to 10 (high risk).
HIV testing history. The time since participants’ most
recent HIV test was categorized as within 1 year; 1 to 2 years;
and 3 or more years; persons with no prior HIV test comprised the
reference group. Clients were also asked about the total number of
times they had previously tested for HIV, categorized as 0, 1, 2, 3,
and 4 or more tests.
HIV related stigma. HIV-related stigma was assessed using
11 questions in two domains, ‘‘internal stigma’’ (6 questions) and
‘‘witnessed stigma’’ (5 questions; see Table S2). Responses in each
domain were added to create stigma scores, with higher scores
indicating higher degrees of stigma (see Table S2). Stigma
indicators were recommended for use in developing countries
and previously validated in Tanzania [17].
Barriers to HIV testing. Two questions, previously used by
NIMH Project Accept [18,19], assessed fears of HIV testing and
test disclosure: ‘‘Most people in my area who want to get tested for
HIV are afraid to get tested;’’ and ‘‘Most people in my area who
want to get tested for HIV don’t want other people to find out if
they get tested.’’ Response options were ‘‘strongly disagree’’,
‘‘disagree’’, ‘‘agree’’, and ‘‘strongly agree;’’ responses were coded
from 0 to 3. Clients who had not previously tested for HIV were
also asked about reasons for not having tested, including the cost of
the test or transportation, distance to testing sites, inability to leave
work, doubts about the confidentiality of the test result, and other
reasons.
Statistical Analysis
Gender-specific logistic regression models predicting MVCT
participation were used to compare characteristics of MVCT
clients and non-participating community clients. Bivariable and
multivariable logistic regression models evaluated associations of
MVCT participation with socio-demographic, economic, and
HIV risk characteristics, as well as HIV testing histories, HIV
related stigma, and testing-related fears. Among respondents who
reported no prior HIV test, multivariable models assessed
associations of MVCT participation with HIV risk and reasons
for never having been tested. Differential distributions of reasons
for never having previously tested between first-time testers and
community-based never testers were used to draw inferences about
barriers to testing. Models were estimated with robust standard
errors and village level fixed effects.
Weighting. The MVCT cohort was comprised of all eligible
testers in the four study villages. However, the cohort of non-
testers represented only a random sample of eligible non-testers.
To allow for estimates of the effects of differences between testers
and non-testers on rates of MVCT participation, multivariable
regression models were estimated with sampling weights to
account for eligible community members not included in either
the MVCT or community cohorts. Sampling weights were defined
as village and gender-specific ratios of MVCT clients to randomly
selected community respondents who presented for testing.
Estimates from weighted regression models were used to
simulate the effects of correlates of MVCT participation on rates
of testing in the four study villages.
Results
Characteristics of study participants
Of 680 eligible residents in randomly selected households, 644
(94.7%) agreed to participate; 397 (61.6%) of these were female;
341 (53.0%) had previously tested for HIV. Nine (1.4%) reported
being HIV-infected. MVCT was attended by 917 clients aged 18–
50 years; 883 (96.3%) agreed to participate in the study (ranging
from 146 to 289 clients per village). MVCT participants comprised
13.9% of the estimated 6,300 age-eligible residents. Of partici-
pating MVCT clients, 423 (47.9%) were female; 432 (48.9%) had
previously tested for HIV. 129 MVCT clients (14.6%) were part of
the randomly selected community sample (range across villages:
9.8% to 20.6%, p= 0.007). Thirty-five MVCT clients (3.9%)
tested HIV seropositive; five (14.3%) of these clients reported that
they were previously aware of their infection and were excluded
from subsequent analyses. Rates of HIV seropositivity among the
remaining 878 MVCT clients ranged from 1.4 to 4.5% across
villages (p = 0.323).
Socio-demographic characteristics
In bivariable comparisons, there were few differences in socio-
demographic characteristics between MVCT clients and commu-
nity respondents who did not present for testing (Table 1). Testers
were more likely to be between the ages of 18–24; male clients
were more likely to report ‘‘unstable’’ income sources, and less
likely to have any children. Female clients were more likely to be
divorced, to be unemployed, to report weekly household
expenditures below 10,000 TZS, and to have had a health care
visit in the past year. Results were similar for all clients and clients
who reported no previous HIV test (not shown). Combining age,
marital status, unemployment and children, male MVCT clients
had a lower socio-demographic risk of HIV seropositivity than
non-testers (OR 0.92, 95% CI 0.86 to 0.98); the difference was not
significant for females.
HIV exposure risk
Female MVCT clients were more likely than female non-
testers to report a greater number of lifetime sexual partners
(OR 2.03, 95% CI 1.28 to 3.22 for 3 lifetime partners, and 2.08,
95% CI 1.22 to 3.55 for 4 to 5 partners; Table 2); differences
were not significant for males. Both male and female MVCT
clients were more likely than non-testers to report two or more
sexual partners in the past 3 months (OR 3.10, 95% CI 1.23 to
7.80 and OR 5.28, 95% CI 1.48 to 18.85, respectively); persons
with one sexual partner in the past 3 months were least likely to
test. Combining the number of lifetime partners, any sexual
partner’s HIV infection, and suspicions about partners’ HIV
infection, MVCT clients exhibited a 21 to 25 percent greater
estimated exposure risk than community-based non-testers (OR
1.20, 95% CI 1.04 to 1.38 for males; OR 1.11, 95% CI 1.03 to
1.19 for females).
Barriers to Mobile HIV Testing Uptake in Tanzania
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HIV testing history
Controlling for MVCT clients’ socio-demographic and exposure
risk, there was no significant association between MVCT participa-
tion and the time since respondents’ last HIV test, though clients
whose most recent test was three or more years ago appeared least
likely to participate (Table 3). Persons who had previously tested 4 or
more times were least likely to test again during the campaigns.
HIV related stigma and testing-related fears
Controlling for HIV risk and testing history, HIV related stigma
and fears of testing or test disclosure were negatively associated with
presentation to MVCT (Table 4; Figure 1). Controlling for HIV risk
and testing history, each additional internal stigma item endorsed, on
average, was associated with 16% lower odds of MVCT
participation for men and 22% lower odds of testing for women;
higher fears were associated with 28% to 54% lower odds.
Compared with persons not endorsing any internal stigma items
(17.8%) those endorsing 4 or more items (19.4%) were less than half
as likely to participate inMVCT (OR: 0.41, 95%CI: 0.22 to 0.76 for
males; OR: 0.25, 95% CI: 0.14 to 0.43 for females; not shown). A
simulation using marginal effects estimates from regression models
including both stigma and testing related fears suggests that a 50%
reduction in HIV related stigma and testing related fears would
result in an 80% increase in MVCT participation among men and
more than a doubling among women (both p,0.001; not shown).
Reasons for not having tested previously
Nearly half of the female study participants and more than half
of the male participants had never tested for HIV. The most
common reasons for never having tested were distance from
available testing sites (33%), not being able to leave work (22%),
and not knowing where to get tested (13%). First time testers in the
MVCT cohort were two to six times as likely as never testers in the
community cohort to cite distance to testing places (OR 2.17, 95%
CI 1.05 to 4.48 for males; OR 5.95, 95% CI 2.85 to 12.45 for
females) and lack of knowledge about available testing options (OR
2.17, 95% CI 0.66 to 7.11 for males; OR 2.83, 95% CI 1.05 to
7.67 for females) as reasons for never having previously tested. By
contrast, MVCT clients were significantly less likely to cite not
being able to leave work as a reason for not having previously
tested. Follow-up assessments among 336 non-testers (67%; results
not shown) indicated that 9% were unaware of the MVCT
campaigns. Of the remaining respondents 25% disclosed that they
were traveling, 20% could not leave work, and 23% mentioned
multiple or recent HIV tests as reasons for not participating.
Eleven percent were either afraid to receive test results, did not
want others in the village to see them testing, or worried about test
confidentiality. Six percent had never thought about getting tested.
Twenty-two percent cited other reasons for not attending MVCT,
such as being busy, forgetting, health issues, or partner
disagreement or unavailability.
Discussion
MVCT campaigns in four villages in rural Kilimanjaro,
Tanzania attracted nearly nine hundred testers during 60 days
of testing; approximately half were female and half were first-time
testers. Relative to community respondents who did not present
Table 1. Sociodemographic characteristics of MVCT clients and randomly selected community respondents who did not present
for testing: estimates from bivariable logistic regression models predicting MVCT participation.
Male
Testers
Non-
testers Odds Ratios 4
Female
Testers
Non-
testers Odds Ratios 4
% OR [95% CI] % OR [95% CI]
Number of observations 460 187 418 319
Age1 18–24 30.4 22.5 ref 26.6 23.3 ref
25–29 16.1 16.0 0.68 [0.39–1.20] 16.5 18.6 0.77 [0.49–1.23]
30–39 29.3 36.9 0.53** [0.33–0.86] 27.8 32.4 0.78 [0.52–1.17]
40–50 24.1 24.6 0.65 [0.39–1.09] 29.2 25.8 1.07 [0.71–1.61]
Marital status1 Married 50.0 52.4 ref 64.4 69.2 ref
Divorced 6.3 4.8 1.45 [0.66–3.18] 10.0 5.3 2.18** [1.20–3.94]
Widowed 1.1 0.5 2.19 [0.24–20.03] 5.3 2.8 2.00 [0.89–4.50]
Single 42.6 42.2 1.13 [0.77–1.64] 20.3 22.6 0.98 [0.68–1.43]
Secondary education 18.3 20.9 0.99 [0.63–1.54] 13.4 13.2 1.11 [0.71–1.76]
Weekly household expenses ,TSH 10,000 23.9 18.2 1.36 [0.87–2.12] 32.5 23.6 1.47* [1.04–2.05]
Income source2 ‘Stable’ income 44.7 47.6 ref 51.6 51.7 ref
Income from farming 28.3 38.5 0.80 [0.52–1.22] 28.1 31.5 0.81 [0.57–1.16]
‘Unstable’ income 27.0 13.9 1.99** [1.22–3.24] 20.4 16.7 1.05 [0.69–1.60]
Unemployed1 1.1 2.1 0.36 [0.09–1.40] 1.2 11.9 0.07** [0.03–0.20]
Any children1 59.8 69.0 0.61* [0.41–0.90] 85.2 88.7 0.72 [0.46–1.15]
Health care visit in the past year 51.1 47.1 1.23 [0.87–1.72] 64.1 51.6 1.71** [1.24–2.35]
Socio-demographic HIV risk index (0- 10)3 3.9 4.4 0.92* [0.86–0.98] 3.8 4.0 0.95 [0.88–1.03]
1Components of the risk index describing sociodemographic correlates of HIV infection;
2‘‘stable’’ income includes business, students, skilled, and salaried labor; ‘‘unstable’’ income include unskilled labor, other income, and unemployment;
3risk index calculated using parameter estimates from Table S1, rescaled to range from 0 (minimum) to 10 (maximum);
4Bivariable odds ratios and 95% confidence intervals (CI) from logistic regression predicting MVCT participation, controlling for village effects.
doi:10.1371/journal.pone.0016488.t001
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Table 2. HIV exposure risk of MVCT clients and randomly selected community respondents who did not present for testing:
estimates from bivariable logistic regression models predicting MVCT participation.
Males Females
Testers
Non-
testers Odds Ratios 3 Testers
Non-
testers Odds Ratios 3
% OR [95% CI] % OR [95% CI]
Number of observations 460 187 418 319
Lifetime partners1 0-1 16.8 18.3 ref 40.5 49.1 ref
2 12.9 16.1 0.82 [0.44–1.54] 21.6 24.5 1.16 [0.78–1.73]
3 17.6 21.5 0.85 [0.47–1.52] 19.7 12.6 2.03** [1.28–3.22]
4-5 22.0 19.9 1.11 [0.62–1.99] 13.9 8.8 2.08** [1.22–3.55]
6+ 30.7 24.2 1.27 [0.71–2.26] 4.3 5.0 1.12 [0.53–2.38]
Partner in past 3 months 0 34.1 29.0 ref 22.5 17.3 ref
1 52.8 67.7 0.63* [0.42–0.94] 70.3 81.8 0.62* [0.42–0.91]
2+ 13.0 3.2 3.10* [1.23–7.80] 7.2 0.9 5.26* [1.48–18.79]
Any partner tested HIV positive (%)1 0.9 0.0 n/a 0.7 0.0 n/a
Suspects any partner has HIV (%)1 5.0 2.1 2.34 [0.79–6.93] 1.4 0.3 5.67 [0.69–46.57]
Any sexual partner died (%) 7.2 7.5 0.90 [0.47–1.71] 7.9 5.0 1.58 [0.86–2.92]
HIV exposure risk index
(range 0 to 10) 2
1.5 1.2 1.20* [1.04–1.38] 2.7 2.2 1.11** [1.03–1.19]
1Components of the risk index describing HIV exposure risk;
2risk index calculated using parameter estimates from Table S1, rescaled to range from 0 (minimum) to 10 (maximum);
3bivariable odds ratios from logistic regression predicting MVCT participation, controlling for village fixed effects; n/a indicates that odds ratios and confidence intervals
could not be estimated.
doi:10.1371/journal.pone.0016488.t002
Table 3. HIV risk selection and testing history among MVCT clients relative to community based non-testers: estimates from
multivariable logistic regression models predicting MVCT participation.
Males Females
Testers
Non-
testers Odds Ratios 2,3 Testers
Non-
testers Odds Ratios 2,3
% OR [95% CI] % OR [95% CI]
Number of observations 458 186 417 318
Risk indices (0 to 10) 1,2 Exposure risk 3.9 4.4 0.89** [0.82–0.96] 3.8 4.0 0.92 [0.84–1.01]
Demographic risk 1.5 1.2 1.26** [1.08–1.47] 2.7 2.2 1.09* [1.01–1.19]
Total risk 3.7 3.9 0.92 [0.84–1.01] 4.4 4.3 1.00 [0.92–1.08]
Time since last HIV test3 Never tested 54.8 59.7 ref 46.8 42.6 ref
Past year 38.4 30.1 1.42 [0.93–2.17] 36.5 35.6 0.76 [0.53–1.09]
1-2 years ago 3.9 3.2 1.90 [0.75–4.86] 12.2 14.8 0.66 [0.40–1.10]
3+ years ago 2.8 7.0 0.53 [0.23–1.25] 4.6 6.9 0.58 [0.28–1.20]
Number of previous tests3 None 54.8 59.7 ref 46.8 42.6 ref
1 24.5 14.0 1.88* [1.10–3.19] 25.7 18.3 1.02 [0.67–1.57]
2 12.7 11.3 1.33 [0.74–2.41] 18.7 19.6 0.75 [0.49–1.17]
3 5.2 8.6 0.79 [0.40–1.57] 6.7 14.5 0.38** [0.21–0.67]
4 or more 2.8 6.5 0.46 [0.19–1.15] 2.2 5.0 0.30* [0.12–0.78]
1Risk indices calculated using parameter estimates from Table S1, rescaled to range from 0 (minimum) to 10 (maximum);
2odds ratios from multivariable logistic regressions predicting MVCT participation, controlling for time since last HIV test and village effects;
3odds ratios from multivariable logistic regression models predicting MVCT participation, controlling for estimated total risk and village effects.
Note: 5 clients with missing information on testing history excluded from analyses.
doi:10.1371/journal.pone.0016488.t003
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for testing, MVCT attracted persons with greater HIV exposure
risk. MVCT clients reported greater numbers of recent and
lifetime partners and higher rates of known or suspected HIV-
infected partners. MVCT also appeared to help overcome
socioeconomic barriers to testing. Compared with non-testers,
female MVCT clients were more likely to report low weekly
household expenditures; male clients were more likely to report
unstable income sources. First-time testers were significantly more
likely than never testers to report distance from testing sites as a
reason for never having tested previously. There was no indication
that MVCT disproportionately attracted first time or frequent
repeat testers.
MVCT, even when conducted by non-residents of the villages,
did not appear to overcome HIV related stigma or fears of testing
or test disclosure. AIDS-related stigma has been identified in other
African settings as an important factor in testing decisions
[10,11,20,21,22]. In Uganda, focus group discussions have
highlighted how even home-based testing programs can be limited
by stigma and that family-inflicted stigma is a particular concern
among women [21]. Among patients with tuberculosis in Ethiopia,
qualitative work also suggested that stigma is major reason for
non-acceptance of HIV testing [22]. Incorporating community-
based educational campaigns aimed at mitigating stigma and fears
of testing or test disclosure may improve the effectiveness of
MVCT campaigns in attracting additional at-risk clients
[4,23,24,25].
Several additional findings of this study deserve mention as they
have the potential to inform HIV counseling and testing related
policy. First, among women, a recent health care visit was
associated with increased odds of presentation for MVCT. While
illness may be a common determinant for the utilization of both
services, 58% of female and 47% of male MVCT clients who had
not previously tested reported a health care visit in the past year,
suggesting persisting missed opportunities for provider-based HIV
testing.
Second, local accessibility of MVCT did not appear to
overcome working persons’ barriers to testing. Not being able to
leave work was the second most frequently cited reason for never
having tested previously; it was also associated with significantly
reduced odds of MVCT participation. It may be necessary to
expand MVCT availability to evening hours and weekends to
allow these persons to get tested, or to promote HIV testing
campaigns in the workplace, particularly if such testing can be
linked to care [26].
Third, the lack of differences in the overall risk distribution and
testing histories between MVCT clients and persons who did not
present for testing suggests that rates of seropositivity at MVCT
campaigns may be useful proxies for HIV prevalence estimates at
local levels. On a large scale, this is supported by national rates of
seropositivity during Tanzania’s national HIV testing campaign
(5.4%) [9], which were comparable to seroprevalence estimates
from the 2007-08 Tanzania HIV/AIDS and Malaria Indicator
Survey (5.7%) [27]. However, repeat testing of clients who
previously tested positive remains a concern: 5 HIV infected
MVCT clients (14%) reported to have previously tested positive;
self-reported testing histories among other HIV infected clients (3
HIV infected clients reported a test within the past year; 3 others a
test 1 to 2 years ago) suggest that this estimate may be
conservative.
We acknowledge several limitations of this study. First, while
refusal rates in the community cohort were low, and multiple
contact attempts were made at all eligible households, including on
Saturdays and Sundays, it is possible that non-availability may
have biased the community sample toward those with no or less
stable income sources; it is not clear whether such biases were
amplified or reduced in the MVCT cohort. It is also possible that
Table 4. Barriers to MVCT participation: estimates from multivariable logistic regression models predicting MVCT participation.
Males Females
Testers
Non-
testers Odds Ratios3 Testers Non-testers Odds Ratios3
Mean or % OR [95% CI] Mean or % OR [95% CI]
All persons 458 186 417 318
HIV Stigma Indices1
Internal stigma (0-6) 2.0 2.4 0.84** [0.74–0.94] 1.8 2.3 0.78** [0.71–0.87]
Witnessed stigma (0-5) 0.8 1.0 0.90 [0.77–1.05] 0.9 1.0 1.06 [0.93–1.20]
Attitudes re: HIV testing2
Fear of testing (0-3) 2.1 2.4 0.53** [0.39–0.71] 2.1 2.5 0.46** [0.36–0.60]
Fear of test disclosure (0-3) 2.2 2.4 0.72* [0.54–0.96] 2.1 2.5 0.50** [0.39–0.64]
Never testers only 251 111 195 135
Reasons cited for never having tested (%)
Too expensive to pay for test or transport 9.2 9.9 0.90 [0.36–2.27] 14.4 10.4 1.66 [0.72–3.83]
Testing site too far from home 39.8 22.5 2.17* [1.05–4.48] 43.1 17.0 5.95** [2.85–12.45]
Didn’t know where to get tested 14.7 4.5 2.17 [0.66–7.11] 20.5 5.9 2.83* [1.05–7.67]
Can’t leave work to get tested 23.9 38.7 0.38** [0.21–0.71] 7.7 25.2 0.11** [0.04–0.30]
Doubted confidentiality of test results 3.6 8.1 0.48 [0.14–1.68] 6.7 8.1 0.98 [0.32–2.99]
Other reasons 49.8 71.2 0.48* [0.26–0.86] 55.4 73.5 0.64 [0.32–1.30]
1See Table S2 for components of stigma indices;
2refer to the methods section for definition;
3models control for clients’ estimated risk of HIV seropositivity, time since last test and number of prior tests, if applicable, and village effects.
doi:10.1371/journal.pone.0016488.t004
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some MVCT participants may have used different identities, thus
precluding their linkage to prior HAARS data. The weighting
procedures assumed that testers and non-testers were representa-
tive of all testers and non-testers in the four study villages,
however, the validity of this assumption cannot be evaluated.
Second, risk estimates were based on self reports and thus are
likely to represent low estimates; it is also not clear whether such
biases apply equally to both cohorts. Third, due to the small
number of newly diagnosed HIV infections it was not possible to
validate the risk model within our study population. Trend tests,
however, suggest an elevated predicted risk among both newly
diagnosed female MVCT clients (p = 0.007) and newly diagnosed
male MVCT clients (p = 0.043; Table S1). Finally, the study was
conducted in four villages in one region of Tanzania, and
differences between villages were observed across all domains of
investigation, including village characteristics, risk of seropositivity,
rates of never testing, and the distribution of correlates of and rates
of MVCT participation. This study was not designed or powered
to provide estimates at the village level. Future studies should
assess the extent to which the observed relationships hold in other
areas and whether correlates of MVCT participation differ across
villages.
In summary, MVCT successfully attracted men and women
with increased exposure risk and appeared to offset economic and
logistical barriers to testing, but did not overcome HIV-related
stigma or fears of testing or test disclosure. MVCT campaigns and
other expanded testing options should be honed further to reduce
stigma and attract additional high-risk testers. While optimal
testing strategies will differ for different communities, free MVCT
campaigns in rural villages appear to be broadly acceptable to
wide cross- sections of the intended target population.
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Figure 1. Odds ratios for participation in mobile HIV voluntary counseling and testing by internal HIV stigma index. Odds ratios and
95% confidence intervals are shown for MVCT participation, relative to stigma score of 0. Controlling for HIV risk and testing history, each additional
internal stigma item endorsed, on average, was associated with 16% lower odds of MVCT participation for men and 22% lower odds of testing for
women.
doi:10.1371/journal.pone.0016488.g001
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